Zevra Therapeutics(ZVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZVRA Zevra Therapeutics

未开盘 04-15 16:00:00 EDT

10.32

+0.53

+5.41%

盘后10.14

-0.18-1.74%

19:59 EDT

最高10.35	最低9.81	成交量73.21万
今开9.81	昨收9.79	日振幅5.52%
总市值6.06亿	流通市值5.37亿	总股本5,871万
成交额741.27万	换手率1.41%	流通股本5,207万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZVRA","market":"US","secType":"STK","nameCN":"Zevra Therapeutics","latestPrice":10.32,"timestamp":1776283200000,"preClose":9.79,"halted":0,"volume":732110,"hourTrading":{"tag":"盘后","latestPrice":10.14,"preClose":10.32,"latestTime":"19:59 EDT","volume":25205,"amount":259292.089,"timestamp":1776297596287,"change":-0.18,"changeRate":-0.017442,"amplitude":0.027132},"delay":0,"changeRate":0.05413687436159358,"floatShares":52073700,"shares":58711584,"eps":1.349999,"marketStatus":"未开盘","change":0.53,"latestTime":"04-15 16:00:00 EDT","open":9.81,"high":10.35,"low":9.81,"amount":7412686.961,"amplitude":0.055158,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.349999,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776326400000},"marketStatusCode":0,"adr":0,"listingDate":1429156800000,"exchange":"NASDAQ","adjPreClose":9.79,"preHourTrading":{"tag":"盘前","latestPrice":9.88,"preClose":9.79,"latestTime":"07:53 EDT","volume":47,"amount":462.04980900000004,"timestamp":1776253984985,"change":0.09,"changeRate":0.009193,"amplitude":0.00715},"postHourTrading":{"tag":"盘后","latestPrice":10.14,"preClose":10.32,"latestTime":"19:59 EDT","volume":25205,"amount":259292.089,"timestamp":1776297596287,"change":-0.18,"changeRate":-0.017442,"amplitude":0.027132},"volumeRatio":1.128237,"impliedVol":0.4023,"impliedVolPercentile":0.224},"requestUrl":"/m/hq/s/ZVRA","defaultTab":"news","newsList":[{"id":"1106767625","title":"Zevra Therapeutics依据纳斯达克规则向新任首席财务官授予股权激励奖励","url":"https://stock-news.laohu8.com/highlight/detail?id=1106767625","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106767625?lang=zh_cn&edition=full","pubTime":"2026-03-21 04:36","pubTimestamp":1774038962,"startTime":"0","endTime":"0","summary":"波士顿，2026年3月20日 —— 专注于为罕见病患者提供治疗方案的商业阶段公司 Zevra Therapeutics, Inc.今日宣布，公司已于2026年3月18日根据其《2023年入职奖励计划》，向新任首席财务官贾斯汀·伦兹授予了一项股权激励奖励。该股权奖励已由公司董事会薪酬委员会根据纳斯达克规则5635批准，并作为伦兹先生接受Zevra聘用的一项重要激励条件。Zevra Therapeutics, Inc. 是一家商业阶段公司，拥有后期产品管线，致力于重新定义可能性，为罕见病患者带来改变生命的疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA","NQmain","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199434786","title":"Zevra Therapeutics依据纳斯达克上市规则5635(C)(4)向新任首席财务官授予激励性股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1199434786","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199434786?lang=zh_cn&edition=full","pubTime":"2026-03-21 04:31","pubTimestamp":1774038672,"startTime":"0","endTime":"0","summary":"Zevra Therapeutics宣布，已根据纳斯达克上市规则5635(C)(4)的规定，向公司新任首席财务官授予了一项激励性股权。此项授予是作为其入职公司的激励方案的一部分，符合相关法规要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148303103","title":"Zevra Therapeutics任命Justin Renz为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1148303103","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148303103?lang=zh_cn&edition=full","pubTime":"2026-03-05 20:33","pubTimestamp":1772714035,"startTime":"0","endTime":"0","summary":"佛罗里达州锡利布雷申，2026年3月5日——专注于为罕见病患者提供治疗方案的商业阶段公司Zevra Therapeutics今日宣布，任命Justin Renz为首席财务官，自2026年3月9日起生效。Renz先生在生物制药行业拥有超过25年的财务领导经验，在资本市场、战略交易和商业阶段运营方面具备深厚专长。他还曾在Karyopharm Pharmaceuticals担任执行副总裁、首席财务官兼财务主管，并在Zalicus Inc.担任执行副总裁兼首席财务官。Zevra Therapeutics是一家目标驱动的商业阶段公司，致力于为罕见病患者带来改变生命的疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155322113","title":"Zevra Therapeutics签署分销协议，扩大尼曼匹克病C型治疗药物Miplyffa®的可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1155322113","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155322113?lang=zh_cn&edition=full","pubTime":"2025-12-29 20:30","pubTimestamp":1767011416,"startTime":"0","endTime":"0","summary":"Zevra Therapeutics（纳斯达克代码：ZVRA）今日宣布，公司已成功签署一项分销协议，旨在显著提升其核心产品Miplyffa®在治疗尼曼匹克病C型（NPC）领域的市场覆盖范围。该协议的落地预计将优化药物供应链，为更多NPC患者提供便捷的治疗选择。此次战略合作标志着Zevra Therapeutics在推动罕见病疗法普及方面迈出关键一步，有望进一步巩固其在专科治疗领域的市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122149310","title":"Zevra Therapeutics任命Timothy Sangiovanni为临时首席财务官 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1122149310","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122149310?lang=zh_cn&edition=full","pubTime":"2025-12-18 05:18","pubTimestamp":1766006289,"startTime":"0","endTime":"0","summary":"Zevra Therapeutics任命Timothy Sangiovanni为临时首席财务官 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100106090","title":"新闻发布：Zevra Therapeutics，Inc. 任命 Alicia Secor 为董事会成员；宣布 Wendy Dixon, PhD 决定退休","url":"https://stock-news.laohu8.com/highlight/detail?id=1100106090","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100106090?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:33","pubTimestamp":1764678829,"startTime":"0","endTime":"0","summary":"庆祝活动，佛罗里达州，2025年12月2日—— Zevra Therapeutics, Inc.是一家专注于为罕见疾病患者提供治疗的商业阶段公司，今天宣布任命 Alicia Secor 为公司董事会（董事会）成员。同时，公司还宣布董事 Wendy Dixon, PhD 的退休，立即生效。Zevra 董事会主席 Tamara A. Favorito 说。Secor 女士曾是 Orchard Therapeutics plc 的董事会成员，该公司是一家在美国纳斯达克市场上市的全球基因治疗公司，直至2024年1月被收购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131964730","title":"Zevra Therapeutics, Inc. 任命 Alicia Secor 为董事会成员；宣布 Wendy Dixon, Phd 退休","url":"https://stock-news.laohu8.com/highlight/detail?id=1131964730","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131964730?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:30","pubTimestamp":1764678613,"startTime":"0","endTime":"0","summary":"Zevra Therapeutics, Inc. 任命 Alicia Secor 为董事会成员，并宣布 Wendy Dixon, Phd 退休。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187097867","title":"Zevra Therapeutics Inc：首席财务官 R. Laduane Clifton 将辞去职务","url":"https://stock-news.laohu8.com/highlight/detail?id=1187097867","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187097867?lang=zh_cn&edition=full","pubTime":"2025-11-21 05:06","pubTimestamp":1763672769,"startTime":"0","endTime":"0","summary":"Zevra Therapeutics Inc：首席财务官 R. Laduane Clifton 将辞去职务","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517164643","title":"Zevra Therapeutics, Inc.盘中异动 早盘急速拉升5.06%报8.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517164643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517164643?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:44","pubTimestamp":1741275845,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时44分，Zevra Therapeutics, Inc.股票出现异动，股价急速拉升5.06%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306234405abeb89b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306234405abeb89b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","LENZ","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514385254","title":"Zevra Therapeutics, Inc.盘中异动 快速拉升5.28%报7.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385254?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666740,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Zevra Therapeutics, Inc.股票出现波动，股价大幅上涨5.28%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223220abdf6ece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223220abdf6ece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","ZVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508468381","title":"Zevra Therapeutics, Inc.盘中异动 快速拉升5.04%报8.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508468381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508468381?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:03","pubTimestamp":1738681413,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时03分，Zevra Therapeutics, Inc.股票出现异动，股价大幅拉升5.04%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204230333a2392f90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204230333a2392f90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ZVRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485294101","title":"Zevra Therapeutics, Inc.盘中异动 快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485294101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485294101?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:47","pubTimestamp":1732297662,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时47分，Zevra Therapeutics, Inc.股票出现波动，股价大幅上涨5.15%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123014742971a8271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123014742971a8271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","ZVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484677092","title":"Zevra Therapeutics, Inc.2024财年第三财季实现净利润-33.23百万美元，同比减少136.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484677092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484677092?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:00","pubTimestamp":1731945627,"startTime":"0","endTime":"0","summary":"11月19日，Zevra Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-33.23百万美元，同比减少136.51%；其中营业收入为3.70百万美元，同比增加27.59%，每股基本收益为-0.70美元。从资产负债表来看，Zevra Therapeutics, Inc.总负债1.22亿美元，其中短期债务540000.00美元，资产负债比为1.58，流动比率为2.89。机构评级：截至2024年11月19日，当前有7家机构对Zevra Therapeutics, Inc.目标价做出预测，其中目标均价为20.14美元，其中最低目标价为15.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000036a2435260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000036a2435260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483385833","title":"Zevra Therapeutics, Inc.盘中异动 急速上涨5.08%报9.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385833?lang=zh_cn&edition=full","pubTime":"2024-11-15 02:15","pubTimestamp":1731608114,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日02时15分，Zevra Therapeutics, Inc.股票出现异动，股价大幅拉升5.08%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115021514a2384cbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115021514a2384cbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ZVRA","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483884503","title":"Zevra Therapeutics, Inc.盘中异动 快速跳水5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483884503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483884503?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:30","pubTimestamp":1731508245,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时30分，Zevra Therapeutics, Inc.股票出现异动，股价急速下跌5.83%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322304698e42584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322304698e42584&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2473258105","title":"Zevra Therapeutics, Inc.盘中异动 早盘大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473258105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473258105?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:37","pubTimestamp":1728308262,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时37分，Zevra Therapeutics, Inc.股票出现异动，股价快速上涨5.14%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721374398e3ad93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721374398e3ad93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","BK4007","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2470110086","title":"Zevra Therapeutics, Inc.盘中异动 股价大跌6.84%报6.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470110086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470110086?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:37","pubTimestamp":1727444237,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时37分，Zevra Therapeutics, Inc.股票出现异动，股价快速下跌6.84%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213717ab6682b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213717ab6682b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","ZVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2468662514","title":"Zevra Therapeutics, Inc.盘中异动 快速拉升5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468662514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468662514?lang=zh_cn&edition=full","pubTime":"2024-09-20 21:30","pubTimestamp":1726839050,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日21时30分，Zevra Therapeutics, Inc.股票出现波动，股价快速上涨5.99%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202130509719c006&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202130509719c006&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2468772265","title":"Zevra Therapeutics, Inc.盘中异动 早盘大幅拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468772265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468772265?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:31","pubTimestamp":1726752667,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时31分，Zevra Therapeutics, Inc.股票出现异动，股价急速上涨5.24%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为1021.42%、333.61%、70.43%，振幅较大的相关个股有Exicure, Inc.、Autolus Therapeutics Plc、Renovaro Inc.，振幅分别为18.34%、11.37%、9.65%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213107a1db3116&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213107a1db3116&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","ZVRA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zevra.com","stockEarnings":[{"period":"1week","weight":0.0761},{"period":"1month","weight":0.0456},{"period":"3month","weight":0.1441},{"period":"6month","weight":-0.0449},{"period":"1year","weight":0.4828},{"period":"ytd","weight":0.1518}],"compareEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0111},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.3019},{"period":"ytd","weight":0.0264}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zevra Therapeutics, Inc.于2006年10月，在爱荷华州注册成立，并在2014年5月于特拉华州重组。该公司是一家罕见病公司，将科学、数据和患者需求结合起来，为治疗选择有限或没有治疗选择的疾病创造转化疗法。该公司的使命是为患有罕见疾病的人带来改变生活的疗法。凭借独特的、数据驱动的开发和商业化战略，该公司正在克服复杂的药物开发挑战，为罕见病社区提供新疗法。该公司拥有多样化的产品组合和候选产品，其中包括临床前开发计划、临床阶段管道和商业阶段资产。该公司团队拥有专业知识，并在通过平衡科学和数据与患者需求的方法推进面临复杂临床和监管挑战的有前途的疗法方面有着成功的记录。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.028378},{"month":2,"riseRate":0.545455,"avgChangeRate":0.044901},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.043273},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.021366},{"month":5,"riseRate":0.529412,"avgChangeRate":-0.02501},{"month":6,"riseRate":0.7,"avgChangeRate":0.030108},{"month":7,"riseRate":0.454545,"avgChangeRate":0.018183},{"month":8,"riseRate":0.545455,"avgChangeRate":0.07256},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.025126},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.086846},{"month":11,"riseRate":0.454545,"avgChangeRate":0.046882},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.02796}],"exchange":"NASDAQ","name":"Zevra Therapeutics","nameEN":"Zevra Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zevra Therapeutics(ZVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zevra Therapeutics(ZVRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zevra Therapeutics,ZVRA,Zevra Therapeutics股票,Zevra Therapeutics股票老虎,Zevra Therapeutics股票老虎国际,Zevra Therapeutics行情,Zevra Therapeutics股票行情,Zevra Therapeutics股价,Zevra Therapeutics股市,Zevra Therapeutics股票价格,Zevra Therapeutics股票交易,Zevra Therapeutics股票购买,Zevra Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zevra Therapeutics(ZVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zevra Therapeutics(ZVRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}